Advancing our dialogue with India for Covid-19 vaccine, says Pfizer

Pfizer was exploring opportunities to make its Covid-19 vaccine available in India and that if successful, its vaccine had the potential to be an important part of India’s early vaccine response to the pandemic , a company spokesperson told Business Standard. 

Pfizer is committed to ensure the availability of its Covid vaccine for use by governments across the world. It said it remains committed to engaging with the Government of India to advance its dialogue and explore opportunities to make its vaccine available for use in the country.

Most vaccines need cold chain storage and Pfizer has developed detailed logistical plans and tools to support effective vaccine transport, storage, and continuous temperature monitoring. 

Initially, its potential vaccine will need to be stored at minus 75 degrees Celsius (plus/minus 15 degrees Celsius). 

“We have experience working with customers in all markets and have developed comprehensive solutions to partner countries to help in the deployment of this vaccine,” the company said.

Pfizer has created two dedicated supply lines with established vaccine capabilities – one each in the US and Europe – to exclusively manufacture this vaccine for use across the world.

Once the pandemic supply phase is over and the company enters a phase of regular supplies, Pfizer will evaluate all additional opportunities available.